Drug Approval | September 30, 2024
USFDA completes inspection at Biocon Biologics’ Insulins facility at Malaysia
The inspection concluded with the issuance of a form 483 with five observations
The inspection concluded with the issuance of a form 483 with five observations
Krsnaa Diagnostics receives LoI from RINPAS for radiology services
This case is an isolated case, similar to the earlier 30 cases reported in India from July 2022 onwards
The study observed 2,648 girls, of which 2,300 completed the standard 45-day programme
Vimta Labs through its diagnostic and pathological services business has recorded a revenue of Rs. 30 crores during FY 2024 and Rs. 7 crores in Q1 FY 2025
First-in-human Phase-1 study will evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of SUVN-I6107 in healthy subjects
The new bioeconomy policy rolled out by the Modi government is set to place India as a global leader in the years to come
Roche confirms that its cobas MPXV test, as well as the LightMix research use only kits, detect the latest mpox virus variants
Revolutionary technology will further boost OneSource’s scientific services offerings
Integrated Disease Surveillance Programme (IDSP) strengthened to improve disease surveillance and rapid data reporting
Subscribe To Our Newsletter & Stay Updated
